|
Extracorporeal Whole Body Hyperthermia
A compendium of current knowledge
Section
1
Section 2
Section 3
Section 4
Section 5
Section 6
Section 7
Section 7
Glossary
Glossary
AIDS
(Acquired Immune Deficiency Syndrome)
The late stage of the illness triggered by infection with
Human Immunodeficiency Virus (HIV). According to the official
definition published by the Centers for Disease Control, a
person receives an AIDS diagnosis when he or she has a CD4
lymphocyte (helper T cell) count of less than 200 and/or
certain opportunistic infections common with advanced immune
deficiency.
Antibody
A
disease-fighting protein in the blood created by the B cells
of the immune system, and also known as immunoglobulin.
Antibodies coat, mark for immune destruction, or render
harmless, foreign particles like bacteria, viruses, or harmful
toxins. Antibodies also tag infected cells, making them
vulnerable to attack by the immune system. Each antibody
attaches itself to a single, specific chemical sequence on an
antigen.
Antigen
A foreign substance, usually a protein, that stimulates an
immune response. An antigen contains several sub-units called
epitopes (see entry) that are targets of specific antibodies
and cytotoxic T-lymphocytes.
Cachexia
A profound and marked state of constitutional disorder;
general iii health and malnutrition, wasting.
Cardiac
index
A measurement of the amount of blood pumped out by each
ventricle in one minute (cardiac output) divided by the body
surface area.
Cardiac
output
The amount of blood pumped out by each ventricle in one
minute. It is the product of the heart rate multiplied by the
stroke volume (the volume of blood pumped out by a ventricle
with each heartbeat).
Catheter
A tube inserted into a vessel or cavity for both acute or
long-term applications. Often used to provide temporary access
to arteries or veins for the administration of drugs, for
blood sampling, or pressure measurement.
CD4
The protein structure on the surface of a human cell that
allows HIV to attach, enter, and consequently infect a cell.
CD4 receptors are present on CD4 lymphocytes (helper T cells),
macrophages and dendritic cells, among others. Normally, CD4
acts as an accessory molecule, forming part of larger
structures (such as the T cell receptor) through which T cells
and other cells signal each other.
CD4
Lymphocyte cell
A type of T cell involved in protecting against viral, fungal,
and protozoal infections. The CD4 lymphocyte modulates the
immune response to an infection through a complex series of
interactions with antigen-presenting cells and other types of
lymphocytes. The CD4 lymphocyte is also known as a T helper
cell or helper T cell. The T4 cell is the field marshal of the
immune system.
CD4
Cell count
Also called the CD4 lymphocyte count, this is the most
commonly used surrogate marker for assessing the state of the
immune system. As the CD4 cell count declines, the risk of
developing opportunistic infections increases. The normal
range for CD4 cell counts is 800 to 1500 per cubic millimeter
of blood.
Chemotherapy
The use of chemical agents (drugs) in the treatment of a
disease. The term commonly, but not always, refers to cancer
treatment.
Chronic
Persisting for a long time. Refers to symptoms and diseases
that last for an extended period of time without noticeable
change.
Clinical
Refers to physical signs and symptoms directly observable in
the human body. Pertaining to or founded on the actual
observation and treatment of patients, as distinguished from
theoretical or basic sciences.
Clinical
trial
A study to test an experimental medicine or treatment to see
if it is safe and effective (see Phase I, Phase II, Phase
III).
Cytokine
One of the proteins produced by white blood cells.
Cytomegalovirus
(CMV)
Any of a group of highly host-specific herpes viruses that
infect man, monkeys, or rodents, producing unique large cells
with intracellular inclusion bodies. The virus can cause a
variety of clinical syndromes. Though most are mild or
sub-clinical, CMV can cause cardiomyopathy and CMV retinitis
causes blindness.
Cytotoxicity
The ability to kill cells.
Efficacy
Strength, effectiveness. The ability of an intervention to
produce the desired beneficial effect in expert hands and
under ideal circumstances.
Effector
An organ, gland, or muscle which is capable of being activated
by nerve endings.
Envelope
The outer covering of a virus, sometimes called the coat.
Epitope
A unique molecular shape or sequence carried on a
microorganism that triggers a specific antibody or cellular
immune response.
FDA
(Food and Drug Administration)
The FDA is an agency of the U.S. Department of Health and
Human Services that regulates the testing of experimental
drugs and medical products. Using evidence of safety, efficacy
or equivalence, the FDA approves and regulates the marketing
of medical products.
Helper
T cell
The type of T lymphocyte that orchestrates cellular immunity
by direct contact with other immune cells and by releasing
chemicals called lymphokines; also helps to mediate the
humoral response (see humoral immunity) by interacting with B
cells (antibodies). Also known as the CD4 cell or CD4
lymphoctye T4 cell.
Hepatitis
Inflammation of the liver caused by microbes or chemicals.
Often accompanied by jaundice, enlarged liver, fever, fatigue
and nausea, and high levels of liver enzymes in the blood. Can
become a chronic disease (e.g., cirrhosis).
Homeostasis
A tendency to stability in the normal physiological state of
the organism. Maintenance of the
body's internal environment.
HIV-1
Human Immunodeficiency Virus type l, the retrovirus recognized
as the agent that induces AIDS.
Humoral
immunity
Immunity provided by antibodies released by sensitized B cells
and their plasma cell progeny. Also called antibody-mediated
immunity.
Hyperthermia
Elevated body temperature.
Hyperthermia,
Extracorporeal Whole Body (EWB H)
Elevation of the core body temperature by removing blood from
the patient's body, passing it through an external heater, and
returning it to the patient's circulation.
Hyperthermia,
local
Hyperthermia as applied to contained, localized volumes of
tissue such as individual metastasis, tumors of the breast, or
the prostrate. The size of the treatment area and depth of
penetration depend on the method of applying heat and the
application technique.
Hyperthermia,
regional
Hyperthermia as applied to treat cancers in larger portions of
the patient's body, such as the pelvis, stomach, or limbs. The
bones, air, and fat in the region affect the dispersion of
heat in the area.
Hyperthermia,
Whole Body (WBH)
A procedure that involves the temporary elevation of the
patient's core body temperature to about 42℃
(107.60F). Whole Body Hyperthermia is a systemic
procedure (affecting the whole body) and is being used to
treat a variety of chronic illnesses, primarily in the fields
of oncology and infectious diseases. Both extracorporeal and
non-invasive (e.g., radiant heat) methods have been used to
induce WBH.
Hyperventilation
Abnormally increased pulmonary ventilation (rapid, deep
breathing), resulting in reduction of carbonic acid, which, if
prolonged, may lead to alkalosis.
Interferon
A small protein secreted by virus-infected cells. Interferon
molecules diffuse to nearby cells and bind to membrane
receptors to inhibit the ability of viruses to multiply within
these cells.
Intractable
Unstoppable. For example, intractable pain.
Kaposi's
sarcoma (KS)
An AIDS-defining illness consisting of individual cancerous
lesions caused by an overgrowth of blood vessels. KS typically
appears as pink or purple painless spots or nodules on the
surface of the skin or oral cavity. KS can occur internally as
lesions in the throat, lungs, and throughout the digestive
system.
Karnofsky's
score
An assessment of a person's ability to carry on normal
activities. For instance: normal activity with no complaints
would be scored 100; in bed 50 percent of the time and
requiring considerable assistance and frequent medical care
would be scored 50; moribund would be scored 10.
Latency
A quiescent period during a disease process. In the HIV/AIDS
disease process, clinical latency is an asymptomatic period in
the early years of HIV infection. The period of latency is
characterized in the peripheral blood by near-normal CD4
counts and HIV levels. Recent research indicates the HIV
remains quite active in the lymph nodes during this period.
Cellular latency is the period after HIV has integrated its
genome into a cell's DNA but has not yet begun to replicate.
Leukoplakia
A white patch on a mucous membrane that will not rub off.
Local
hyperthermia
See Hyperthermia, local
Mitogen
A substance that induces mitosis.
Mitosis
The division of the cell nucleus, followed by division of the
cytoplasm of the cell, 1.e., cell duplication.
Monocyte
A white blood cell, it is also a CD4 receptor, i.e., it is
infected by HIV. It is a phagocyte cell, which can migrate out
of the blood stream into tissue, where it becomes known as a
macrophage.
Monokine
A general term for soluble mediators of immune responses that
are not antibodies or complement components and that are
produced by mononuclear phagocytes (monocytes or macrophages).
Mucosa
Mucous membrane.
Myoglobin
Iron-containing protein found in muscle cells, related to
hemoglobin in structure and function.
Natural
killer (NK) cells
Natural killer (NK) cells guard the blood and lymphatic
system. They are a unique group of defensive cells that can
disintegrate and kill cancer cells and virus-infected body
cells.
Neutrophil
Protective white blood cells.
Norepinephrine
A neurotransmitter related to dopamine and adrenaline. As a
peripheral vasoconstrictor, it helps restore blood pressure
during states of low blood pressure.
Phase
I clinical trial
The earliest stage of a trial for studying a new therapy.
Phase I trials are generally small. They provide an initial
evaluation of the safety of the therapy and, depending on the
therapy, preliminary indications of dosage, duration and other
basic information for use in later studies.
Phase
II clinical trial
A more advanced stage of a clinical trial, following a Phase I
trial. A Phase II trial gathers preliminary information on the
efficacy of the therapy. In Phase II trials patients are
randomly assigned to receive the therapy or they are randomly
assigned to a control group which gets the standard treatment
or no treatment at all.
Phase
III clinical trial
An advanced-stage clinical trial that should conclusively show
how well a therapy works in comparison to other treatments.
Phase III trials can be longer and are usually larger than
Phase II trials, and frequently involve multiple test sites.
Their goal is the statistical measurement of how well a
therapy extends the survival of patients or otherwise
clinically improves the health of patients under treatment.
Protocol
The explicit, detailed plan of an experiment, procedure, or
test.
Pyrogenic
Fever inducing.
Remission
Diminution or abatement of the symptoms of a disease; the
period during which such diminution occurs.
Respiratory
quotient (RQ)
A measurement of metabolism. Different biochemical pathways
break down different food components, such as fat, protein and
primary glucose (CHO). Based on the pathway or combination,
the O2 consumed and the CO2 produced are
measured. Primary glucose (CHO) metabolism is equal to or
greater than an RQ of 1.0.
Regional
hyperthermia
See Hyperthermia, regional
Retrovirus
A virus that, when not infecting a cell, stores its genetic
information on a singlestranded RNA molecule instead of the
more usual double-stranded DNA. HIV is an example. After a
retrovirus penetrates a cell, it constructs a DNA version of
its genes using reverse transcriptase, an enzyme. The DNA then
becomes part of the cell's genetic material.
Rhabdomyolysis
Disintegration of striated muscle fibers, with excretions of
myoglobin in the urine.
Rosetting
Formation of clusters of polymorphonuclear leukocytes around a
globule of lipid nuclear material.
Sarcoma
Any of a group of tumors usually arising from connective
tissue. Most are malignant.
Splanchnic
vessels
Any of the vessels of the abdominal organs.
Systemic
Pertaining to the whole body.
Systemic
therapy
Treatment that reaches cells throughout the body by travelling
through the bloodstream.
T
cell (T lymphocyte)
Lymphocytes that mediate cellular immunity. They include
helper, killer, suppressor, and memory cells.
Tumoricidal
Any agent that destroys tumor cells.
Tumor
necrosis factor alpha (TNF α)
A cell toxin released by activated macrophages. Attracts
granulocytes, and activates T cells and macrophages.
Vasoconstriction
A tightening of the smooth muscles of blood vessels, resulting
in a decrease in their inner diameter (caliber).
Vasodilation
Relaxation of the smooth muscles of blood vessels, resulting
in an increase in their inner diameter (caliber).
Veno-venous
A vein-to-vein shunt. Used with First Circle Medical's Temet
system for Extracorporeal Whole Body Hyperthermia to provide a
way to remove blood from the body, heat it, and return it to
the body without the need for an oxygenator.
Viral
load
The number of viral particles found in a sample of blood
plasma. When used to measure HIV viral particles, it is viewed
as a predictor in a patient's progression to AIDS and
subsequent death. This measure has also been used to evaluate
the effectiveness of certain HIV/AIDS treatments. However, it
usually reflects only the viral particles present in the
blood, and does not measure the amount of virus in tissue. The
viral load of tissue can be assessed with a lymphoid tissue
biopsy.
Whole
Body Hyperthermia (WBH)
See Hyperthermia, Whole Body
|